151 related articles for article (PubMed ID: 31766645)
1. Therapeutic Potential of AAV1-Rheb(S16H) Transduction Against Alzheimer's Disease.
Moon GJ; Kim S; Jeon MT; Lee KJ; Jang IS; Nakamura M; Kim SR
J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31766645
[TBL] [Abstract][Full Text] [Related]
2. Neurotrophic interactions between neurons and astrocytes following AAV1-Rheb(S16H) transduction in the hippocampus in vivo.
Jeon MT; Moon GJ; Kim S; Choi M; Oh YS; Kim DW; Kim HJ; Lee KJ; Choe Y; Ha CM; Jang IS; Nakamura M; McLean C; Chung WS; Shin WH; Lee SG; Kim SR
Br J Pharmacol; 2020 Feb; 177(3):668-686. PubMed ID: 31658360
[TBL] [Abstract][Full Text] [Related]
3. Protection of nigral dopaminergic neurons by AAV1 transduction with Rheb(S16H) against neurotoxic inflammation in vivo.
Kim S; Moon GJ; Oh YS; Park J; Shin WH; Jeong JY; Choi KS; Jin BK; Kholodilov N; Burke RE; Kim HJ; Ha CM; Lee SG; Kim SR
Exp Mol Med; 2018 Feb; 50(2):e440. PubMed ID: 29422542
[TBL] [Abstract][Full Text] [Related]
4. Induction of GDNF and GFRα-1 Following AAV1-Rheb(S16H) Administration in the Hippocampus
Yun D; Jeon MT; Kim HJ; Moon GJ; Lee S; Ha CM; Shin M; Kim SR
Exp Neurobiol; 2020 Apr; 29(2):164-175. PubMed ID: 32408406
[TBL] [Abstract][Full Text] [Related]
5. In vivo AAV1 transduction with hRheb(S16H) protects hippocampal neurons by BDNF production.
Jeon MT; Nam JH; Shin WH; Leem E; Jeong KH; Jung UJ; Bae YS; Jin YH; Kholodilov N; Burke RE; Lee SG; Jin BK; Kim SR
Mol Ther; 2015 Mar; 23(3):445-55. PubMed ID: 25502903
[TBL] [Abstract][Full Text] [Related]
6. Treatment with AAV1-Rheb(S16H) provides neuroprotection in a mouse model of photothrombosis-induced ischemic stroke.
Yoon D; Jeon MT; Dong Woon K; Kim SR
Neuroreport; 2020 Sep; 31(13):971-978. PubMed ID: 32694311
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Neuronal Rheb(S16H) for Hippocampal Protection in the Adult Brain.
Moon GJ; Shin M; Kim SR
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188096
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Potential of AAV1-Rheb(S16H) Transduction against Neurodegenerative Diseases.
Nam Y; Moon GJ; Kim SR
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802760
[TBL] [Abstract][Full Text] [Related]
9. Roles of Rheb(S16H) in substantia nigra pars compacta dopaminergic neurons
Jeon MT; Kim SR
Biomed Rep; 2015 Mar; 3(2):137-140. PubMed ID: 25798236
[TBL] [Abstract][Full Text] [Related]
10. Activation of CNTF/CNTFRα signaling pathway by hRheb(S16H) transduction of dopaminergic neurons in vivo.
Jeong KH; Nam JH; Jin BK; Kim SR
PLoS One; 2015; 10(3):e0121803. PubMed ID: 25799580
[TBL] [Abstract][Full Text] [Related]
11. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
12. Conditional BDNF Delivery from Astrocytes Rescues Memory Deficits, Spine Density, and Synaptic Properties in the 5xFAD Mouse Model of Alzheimer Disease.
de Pins B; Cifuentes-Díaz C; Farah AT; López-Molina L; Montalban E; Sancho-Balsells A; López A; Ginés S; Delgado-García JM; Alberch J; Gruart A; Girault JA; Giralt A
J Neurosci; 2019 Mar; 39(13):2441-2458. PubMed ID: 30700530
[TBL] [Abstract][Full Text] [Related]
13. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
14. Apelin-13 Suppresses Neuroinflammation Against Cognitive Deficit in a Streptozotocin-Induced Rat Model of Alzheimer's Disease Through Activation of BDNF-TrkB Signaling Pathway.
Luo H; Xiang Y; Qu X; Liu H; Liu C; Li G; Han L; Qin X
Front Pharmacol; 2019; 10():395. PubMed ID: 31040784
[TBL] [Abstract][Full Text] [Related]
15. The effect of chronic stimulation of serotonin receptor type 7 on recognition, passive avoidance memory, hippocampal long-term potentiation, and neuronal apoptosis in the amyloid β protein treated rat.
Shahidi S; Asl SS; Komaki A; Hashemi-Firouzi N
Psychopharmacology (Berl); 2018 May; 235(5):1513-1525. PubMed ID: 29637287
[TBL] [Abstract][Full Text] [Related]
16. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
17. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
[TBL] [Abstract][Full Text] [Related]
18. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
[TBL] [Abstract][Full Text] [Related]
19. Harpagoside ameliorates the amyloid-β-induced cognitive impairment in rats via up-regulating BDNF expression and MAPK/PI3K pathways.
Li J; Ding X; Zhang R; Jiang W; Sun X; Xia Z; Wang X; Wu E; Zhang Y; Hu Y
Neuroscience; 2015 Sep; 303():103-14. PubMed ID: 26135675
[TBL] [Abstract][Full Text] [Related]
20. Brain-Derived Neurotrophic Factor (BDNF) Preserves the Functional Integrity of Neural Networks in the β-Amyloidopathy Model
Mitroshina EV; Yarkov RS; Mishchenko TA; Krut' VG; Gavrish MS; Epifanova EA; Babaev AA; Vedunova MV
Front Cell Dev Biol; 2020; 8():582. PubMed ID: 32733889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]